The H. Lee Moffitt Cancer Center & Research Institute opened in 1986 on the University of South Florida campus with the mission """"""""to contribute to the prevention and cure of cancer."""""""" The Cancer Center enjoys close ties at multiple levels of the University structure, and benefits from the clearly articulated authorities of the Center Director and the Center's independent financial status. Over the past five years, the Cancer Center has invested over $18 million in research programs, personnel and infrastructure. In addition, a $14 million renovation of the Research Center and other laboratories during the same time period expanded research space from 18,000 sf in 1993 to 90,000 sf currently. The commitment to research complements the strong clinical operation of the hospital, which admits 4,000 inpatients per year; the clinics, which has more than 80,000 patient visits in 1995-96; and the unique Lifetime Cancer Screening Center, which sees more than 7,000 healthy and high risk individuals each year. The Cancer Center's four established research program include Molecular Oncology, Immunology, Clinical Investigations and Cancer Control. The programs have built on the collective strengths of faculty from multiple departments and colleges and the excellence of a strong clinical care setting. The Cancer Center Support Grant will enable the Cancer Center to expand its research focus to include genetics, to be developed as a joint basic science and cancer control effort. Additionally, the CCSG will support expansion of shared resources to accommodate increased usage from growth in personnel and scope of research. Shared resources includes Flow Cytometry, Pathology, Molecular Biology, Glass Wash, Molecular Imaging, Biostatistics, Data Management, and an animal core in the Cancer Research Center which will add transgenic services in the coming year. Most importantly, the CCSG will provide focused support for enhanced development of translational research through support of senior leaders and program leaders in their roles as they work with cancer center members to promote laboratory-clinical-laboratory interactions and translations.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA076292-03
Application #
6150264
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ciolino, Henry P
Project Start
1998-02-19
Project End
2001-01-31
Budget Start
2000-03-14
Budget End
2001-01-31
Support Year
3
Fiscal Year
2000
Total Cost
$1,011,090
Indirect Cost
Name
University of South Florida
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Tampa
State
FL
Country
United States
Zip Code
33612
Gonzalez, Brian D; Hoogland, Aasha I; Kasting, Monica L et al. (2018) Psychosocial impact of BRCA testing in young Black breast cancer survivors. Psychooncology 27:2778-2785
Akuffo, Afua A; Alontaga, Aileen Y; Metcalf, Rainer et al. (2018) Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon. J Biol Chem 293:6187-6200
Mahajan, Nupam P; Coppola, Domenico; Kim, Jongphil et al. (2018) Blockade of ACK1/TNK2 To Squelch the Survival of Prostate Cancer Stem-like Cells. Sci Rep 8:1954
Rounbehler, Robert J; Berglund, Anders E; Gerke, Travis et al. (2018) Tristetraprolin Is a Prognostic Biomarker for Poor Outcomes among Patients with Low-Grade Prostate Cancer. Cancer Epidemiol Biomarkers Prev 27:1376-1383
Christy, Shannon M; Schmidt, Alyssa; Wang, Hsiao-Lan et al. (2018) Understanding Cancer Worry Among Patients in a Community Clinic-Based Colorectal Cancer Screening Intervention Study. Nurs Res 67:275-285
Chang, James M; Kosiorek, Heidi E; Dueck, Amylou C et al. (2018) Stratifying SLN incidence in intermediate thickness melanoma patients. Am J Surg 215:699-706
Ji, Xuemei; Bossé, Yohan; Landi, Maria Teresa et al. (2018) Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk. Nat Commun 9:3221
Sun, X; Ren, Y; Gunawan, S et al. (2018) Selective inhibition of leukemia-associated SHP2E69K mutant by the allosteric SHP2 inhibitor SHP099. Leukemia 32:1246-1249
Porubsky, Caitlin; Teer, Jamie K; Zhang, Yonghong et al. (2018) Genomic analysis of a case of agminated Spitz nevi and congenital-pattern nevi arising in extensive nevus spilus. J Cutan Pathol 45:180-183
Zhu, Genyuan; Nemoto, Satoshi; Mailloux, Adam W et al. (2018) Induction of Tertiary Lymphoid Structures With Antitumor Function by a Lymph Node-Derived Stromal Cell Line. Front Immunol 9:1609

Showing the most recent 10 out of 1254 publications